Istesso

About:

Istesso is a drug discovery and development company working in the field of immunometabolism.

Twitter/X: istesso

Top Investors: IP Group, Parkwalk Advisors

Description:

Istesso is a drug discovery and development company working in the field of immunometabolism. Our pipeline of pre-clinical and clinical assets act by reprogramming metabolism to treat autoimmune and inflammatory conditions such as rheumatoid arthritis and multiple sclerosis. Istesso was founded in 2017 as the holding company for Modern Biosciences Ltd.

Total Funding Amount:

10M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)istesso.co.uk

Founders:

Lisa Patel, Sam Williams

Number of Employees:

11-50

Last Funding Date:

2019-02-01

IPO Status:

Private

Industries: